<HashMap><database>ecrin-mdr-crc</database><scores/><additional><omics_type>Clinical</omics_type><study_start_year>2019</study_start_year><condition>Colorectal Carcinoma</condition><condition>Colorectal Neoplasms</condition><disease>Colorectal Carcinoma</disease><disease>Colorectal Neoplasms</disease><study_type>Interventional</study_type><full_dataset_link>https://newmdr.ecrin.org/Study/2314733</full_dataset_link><location>China</location><study_start_month>10</study_start_month><keyword>Adjuvant chemotherapy</keyword><keyword>Electronic patient reported outcomes</keyword><repository>ECRIN MDR</repository><study_status>Recruiting</study_status></additional><is_claimable>false</is_claimable><name>ePRO for Adjuvant Therapy of Colorectal Adenocarcinoma</name><description>It is a multi-centric randomized controlled trial. The goal of this study is to observe the improvement of QoL using ePRO to manage patients with colorectal cancer who received Oxaliplatin-based adjuvant chemotherapy.The prognosis will also be studied.</description><dates><creation>2019-10-15</creation></dates><accession>2314733</accession><cross_references><ClinicalTrials___gov>NCT04069455</ClinicalTrials___gov></cross_references></HashMap>